Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page
- Check4 days agoChange DetectedReleased a minor version bump from v3.0.1 to v3.0.2. The 'Back to Top' link was removed as a cosmetic UI change.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while also removing specific terms related to renal cell carcinoma and various types of antibodies and antineoplastic agents.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.